Table of Content

1 Market Overview of Small Molecule Targeted Anti-cancer Drug
1.1 Small Molecule Targeted Anti-cancer Drug Market Overview
1.1.1 Small Molecule Targeted Anti-cancer Drug Product Scope
1.1.2 Small Molecule Targeted Anti-cancer Drug Market Status and Outlook
1.2 Global Small Molecule Targeted Anti-cancer Drug Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Small Molecule Targeted Anti-cancer Drug Market Size by Region (2024-2034)
1.4 Global Small Molecule Targeted Anti-cancer Drug Historic Market Size by Region (2024-2024)
1.5 Global Small Molecule Targeted Anti-cancer Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034)
1.6.1 North America Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034)
1.6.2 Europe Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034)
1.6.3 Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034)
1.6.4 Latin America Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034)
1.6.5 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034)
2 Small Molecule Targeted Anti-cancer Drug Market by Type
2.1 Introduction
2.1.1 EGFR
2.1.2 ALK
2.1.3 Bcr-Abl
2.1.4 Others
2.2 Global Small Molecule Targeted Anti-cancer Drug Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Small Molecule Targeted Anti-cancer Drug Historic Market Size by Type (2024-2024)
2.2.2 Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Small Molecule Targeted Anti-cancer Drug Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Small Molecule Targeted Anti-cancer Drug Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Small Molecule Targeted Anti-cancer Drug Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Small Molecule Targeted Anti-cancer Drug Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue Breakdown by Type (2024-2034)
3 Small Molecule Targeted Anti-cancer Drug Market Overview by Application
3.1 Introduction
3.1.1 Liver Cancer
3.1.2 Colorectal Cancer
3.1.3 Lung Cancer
3.1.4 Gastric Cancer
3.1.5 Breast Cancer
3.1.6 Esophageal Cancer
3.1.7 Others
3.2 Global Small Molecule Targeted Anti-cancer Drug Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Small Molecule Targeted Anti-cancer Drug Historic Market Size by Application (2024-2024)
3.2.2 Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Small Molecule Targeted Anti-cancer Drug Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Small Molecule Targeted Anti-cancer Drug Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Small Molecule Targeted Anti-cancer Drug Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Small Molecule Targeted Anti-cancer Drug Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue Breakdown by Application (2024-2034)
4 Small Molecule Targeted Anti-cancer Drug Competition Analysis by Players
4.1 Global Small Molecule Targeted Anti-cancer Drug Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Targeted Anti-cancer Drug as of 2022)
4.3 Date of Key Players Enter into Small Molecule Targeted Anti-cancer Drug Market
4.4 Global Top Players Small Molecule Targeted Anti-cancer Drug Headquarters and Area Served
4.5 Key Players Small Molecule Targeted Anti-cancer Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Small Molecule Targeted Anti-cancer Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Astrazeneca
5.1.1 Astrazeneca Profile
5.1.2 Astrazeneca Main Business
5.1.3 Astrazeneca Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.1.4 Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.1.5 Astrazeneca Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.2.4 Novartis Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.2.5 Novartis Recent Developments
5.3 Millennium Pharmaceuticals
5.3.1 Millennium Pharmaceuticals Profile
5.3.2 Millennium Pharmaceuticals Main Business
5.3.3 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.3.4 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.4.4 Bayer Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.4.5 Bayer Recent Developments
5.5 Exelixis
5.5.1 Exelixis Profile
5.5.2 Exelixis Main Business
5.5.3 Exelixis Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.5.4 Exelixis Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.5.5 Exelixis Recent Developments
5.6 Abbvie
5.6.1 Abbvie Profile
5.6.2 Abbvie Main Business
5.6.3 Abbvie Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.6.4 Abbvie Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.6.5 Abbvie Recent Developments
5.7 Boehringer-Ingelheim
5.7.1 Boehringer-Ingelheim Profile
5.7.2 Boehringer-Ingelheim Main Business
5.7.3 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.7.4 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.7.5 Boehringer-Ingelheim Recent Developments
5.8 Eisai
5.8.1 Eisai Profile
5.8.2 Eisai Main Business
5.8.3 Eisai Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.8.4 Eisai Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.8.5 Eisai Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.9.4 Pfizer Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.9.5 Pfizer Recent Developments
5.10 Bristol-Myers Squibb
5.10.1 Bristol-Myers Squibb Profile
5.10.2 Bristol-Myers Squibb Main Business
5.10.3 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.10.4 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.10.5 Bristol-Myers Squibb Recent Developments
5.11 Roche
5.11.1 Roche Profile
5.11.2 Roche Main Business
5.11.3 Roche Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.11.4 Roche Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.11.5 Roche Recent Developments
5.12 Bettapharma
5.12.1 Bettapharma Profile
5.12.2 Bettapharma Main Business
5.12.3 Bettapharma Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
5.12.4 Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) & (2024-2024)
5.12.5 Bettapharma Recent Developments
6 North America
6.1 North America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Small Molecule Targeted Anti-cancer Drug Market Dynamics
11.1 Small Molecule Targeted Anti-cancer Drug Industry Trends
11.2 Small Molecule Targeted Anti-cancer Drug Market Drivers
11.3 Small Molecule Targeted Anti-cancer Drug Market Challenges
11.4 Small Molecule Targeted Anti-cancer Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Small Molecule Targeted Anti-cancer Drug Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Small Molecule Targeted Anti-cancer Drug Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Small Molecule Targeted Anti-cancer Drug Market Size Share by Region (2024-2024)
Table 4. Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Small Molecule Targeted Anti-cancer Drug Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Small Molecule Targeted Anti-cancer Drug Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2024-2024)
Table 9. Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Small Molecule Targeted Anti-cancer Drug Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Small Molecule Targeted Anti-cancer Drug Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2024-2024)
Table 24. Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Small Molecule Targeted Anti-cancer Drug Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Targeted Anti-cancer Drug as of 2022)
Table 39. Date of Key Players Enter into Small Molecule Targeted Anti-cancer Drug Market
Table 40. Global Small Molecule Targeted Anti-cancer Drug Key Players Headquarters and Area Served
Table 41. Small Molecule Targeted Anti-cancer Drug Product Solution and Service
Table 42. Global Small Molecule Targeted Anti-cancer Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Astrazeneca Basic Information List
Table 45. Astrazeneca Description and Business Overview
Table 46. Astrazeneca Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Astrazeneca (2024-2024)
Table 48. Astrazeneca Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Novartis (2024-2024)
Table 53. Novartis Recent Developments
Table 54. Millennium Pharmaceuticals Basic Information List
Table 55. Millennium Pharmaceuticals Description and Business Overview
Table 56. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Millennium Pharmaceuticals (2024-2024)
Table 58. Millennium Pharmaceuticals Recent Developments
Table 59. Bayer Basic Information List
Table 60. Bayer Description and Business Overview
Table 61. Bayer Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Bayer (2024-2024)
Table 63. Bayer Recent Developments
Table 64. Exelixis Basic Information List
Table 65. Exelixis Description and Business Overview
Table 66. Exelixis Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Exelixis (2024-2024)
Table 68. Exelixis Recent Developments
Table 69. Abbvie Basic Information List
Table 70. Abbvie Description and Business Overview
Table 71. Abbvie Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Abbvie (2024-2024)
Table 73. Abbvie Recent Developments
Table 74. Boehringer-Ingelheim Basic Information List
Table 75. Boehringer-Ingelheim Description and Business Overview
Table 76. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Boehringer-Ingelheim (2024-2024)
Table 78. Boehringer-Ingelheim Recent Developments
Table 79. Eisai Basic Information List
Table 80. Eisai Description and Business Overview
Table 81. Eisai Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Eisai (2024-2024)
Table 83. Eisai Recent Developments
Table 84. Pfizer Basic Information List
Table 85. Pfizer Description and Business Overview
Table 86. Pfizer Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Pfizer (2024-2024)
Table 88. Pfizer Recent Developments
Table 89. Bristol-Myers Squibb Basic Information List
Table 90. Bristol-Myers Squibb Description and Business Overview
Table 91. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Bristol-Myers Squibb (2024-2024)
Table 93. Bristol-Myers Squibb Recent Developments
Table 94. Roche Basic Information List
Table 95. Roche Description and Business Overview
Table 96. Roche Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Roche (2024-2024)
Table 98. Roche Recent Developments
Table 99. Bettapharma Basic Information List
Table 100. Bettapharma Description and Business Overview
Table 101. Bettapharma Small Molecule Targeted Anti-cancer Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Small Molecule Targeted Anti-cancer Drug Business of Bettapharma (2024-2024)
Table 103. Bettapharma Recent Developments
Table 104. North America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2024) & (US$ Million)
Table 105. North America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2034) & (US$ Million)
Table 106. Europe Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2024) & (US$ Million)
Table 107. Europe Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2034) & (US$ Million)
Table 108. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 109. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size by Region (2024-2024) & (US$ Million)
Table 110. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size by Region (2024-2034) & (US$ Million)
Table 111. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Share by Region (2024-2024)
Table 112. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Share by Region (2024-2034)
Table 113. Latin America Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 114. Latin America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2024) & (US$ Million)
Table 115. Latin America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2034) & (US$ Million)
Table 116. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 117. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2024) & (US$ Million)
Table 118. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Country (2024-2034) & (US$ Million)
Table 119. Small Molecule Targeted Anti-cancer Drug Market Trends
Table 120. Small Molecule Targeted Anti-cancer Drug Market Drivers
Table 121. Small Molecule Targeted Anti-cancer Drug Market Challenges
Table 122. Small Molecule Targeted Anti-cancer Drug Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule Targeted Anti-cancer Drug Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Small Molecule Targeted Anti-cancer Drug Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Small Molecule Targeted Anti-cancer Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of EGFR
Figure 11. Global EGFR Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of ALK
Figure 13. Global ALK Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Bcr-Abl
Figure 15. Global Bcr-Abl Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Small Molecule Targeted Anti-cancer Drug Market Size Share by Type: 2022 & 2034
Figure 19. North America Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2024-2034)
Figure 20. Europe Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2024-2034)
Figure 24. Liver Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Colorectal Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Lung Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Gastric Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Breast Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 29. Esophageal Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 30. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 31. Global Small Molecule Targeted Anti-cancer Drug Market Size Share by Application: 2022 & 2034
Figure 32. North America Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2024-2034)
Figure 33. Europe Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2024-2034)
Figure 34. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2024-2034)
Figure 35. Latin America Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2024-2034)
Figure 36. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2024-2034)
Figure 37. Small Molecule Targeted Anti-cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 38. Global Top 5 and Top 10 Players Small Molecule Targeted Anti-cancer Drug Market Share in 2022
Figure 39. North America Small Molecule Targeted Anti-cancer Drug Market Share by Country (2024-2034)
Figure 40. U.S. Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 41. Canada Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 42. Germany Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 43. France Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 44. U.K. Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 45. Italy Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 46. Russia Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 47. Nordic Countries Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 48. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Share by Region (2024-2034)
Figure 49. China Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 50. Japan Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 51. South Korea Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 52. Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 53. India Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 54. Australia Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 55. Latin America Small Molecule Targeted Anti-cancer Drug Market Share by Country (2024-2034)
Figure 56. Mexico Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 57. Brazil Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 58. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Share by Country (2024-2034)
Figure 59. Turkey Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 60. Saudi Arabia Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 61. UAE Small Molecule Targeted Anti-cancer Drug Market Size (2024-2034) & (US$ Million)
Figure 62. Bottom-up and Top-down Approaches for This Report